- Home
- SPH vs OPK Comparison
SPH vs OPK Comparison
Compare SPH & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPH
- OPK
- Stock Information
- Founded
- SPH 1945
- OPK 2007
- Country
- SPH United States
- OPK United States
- Employees
- SPH N/A
- OPK N/A
- Industry
- SPH Other Specialty Stores
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- SPH Consumer Discretionary
- OPK Health Care
- Exchange
- SPH Nasdaq
- OPK Nasdaq
- Market Cap
- SPH 1.2B
- OPK 1.0B
- IPO Year
- SPH 1996
- OPK 1995
- Fundamental
- Price
- SPH $18.71
- OPK $1.40
- Analyst Decision
- SPH
- OPK Buy
- Analyst Count
- SPH 0
- OPK 4
- Target Price
- SPH N/A
- OPK $2.75
- AVG Volume (30 Days)
- SPH 98.3K
- OPK 2.0M
- Earning Date
- SPH 11-13-2025
- OPK 11-06-2025
- Dividend Yield
- SPH 6.99%
- OPK N/A
- EPS Growth
- SPH N/A
- OPK N/A
- EPS
- SPH 1.49
- OPK N/A
- Revenue
- SPH $1,429,783,000.00
- OPK $664,029,000.00
- Revenue This Year
- SPH $10.99
- OPK N/A
- Revenue Next Year
- SPH N/A
- OPK $0.84
- P/E Ratio
- SPH $12.49
- OPK N/A
- Revenue Growth
- SPH 6.29
- OPK N/A
- 52 Week Low
- SPH $16.92
- OPK $1.11
- 52 Week High
- SPH $22.24
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- SPH 54.99
- OPK 53.61
- Support Level
- SPH $18.31
- OPK $1.34
- Resistance Level
- SPH $18.80
- OPK $1.43
- Average True Range (ATR)
- SPH 0.31
- OPK 0.04
- MACD
- SPH 0.03
- OPK -0.00
- Stochastic Oscillator
- SPH 87.14
- OPK 60.00
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.